Rapport Therapeutics
Latest round
- Series B
Last raised
- Aug 2023
Total raised
- $250M
Investors
- 11
About Rapport Therapeutics
Based in Massachusetts, US, and founded in 2022, Rapport Therapeutics, Inc. perform researches and develops precision medicine for treating neurological disorders. The firm was established through a partnership between Third Rock Ventures and Janssen Neuroscience. The company was founded by David Bredt. As of 2023, the firm is headed by its CEO Abraham N. Ceesay. The company offers precision medicine approach, as well as precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). Using receptor-associated proteins, or RAPs, the Rapport platform identifies small molecule therapies that function only on genetically and clinically confirmed targets.
Who invested in Rapport Therapeutics
11 investors across 2 rounds
See all investors in Rapport Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rapport Therapeutics
Who invested in Rapport Therapeutics?
Rapport Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rapport Therapeutics raised?
Rapport Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rapport Therapeutics last raise money?
Rapport Therapeutics's most recent round on record is a Series B, in Aug 2023.
What does Rapport Therapeutics do?
Based in Massachusetts, US, and founded in 2022, Rapport Therapeutics, Inc.
Where is Rapport Therapeutics headquartered?
Rapport Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Rapport Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rapport Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Rapport Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.